Cargando…

Comorbidities in interstitial lung diseases

Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients can die because of the progression of their illness, remain stable or even improve after appropriate treatment has been instituted. Comorbidities, such as acute and chronic infection, gastro-oesophageal refl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Margaritopoulos, George A., Antoniou, Katerina M., Wells, Athol U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488735/ https://www.ncbi.nlm.nih.gov/pubmed/28049126 http://dx.doi.org/10.1183/16000617.0027-2016

Ejemplares similares

Smoking and interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2015)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

Personalised medicine in interstitial lung diseases: Number 6 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
por: Kokosi, Maria A., et al.
Publicado: (2018)

Smoking and Pulmonary Fibrosis: Novel Insights
por: Samara, Katerina D., et al.
Publicado: (2011)

The role of precision medicine in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Funke-Chambour, Manuela, et al.
Publicado: (2022)

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
por: Kewalramani, Namrata, et al.
Publicado: (2022)

Pirfenidone improves survival in IPF: results from a real-life study
por: Margaritopoulos, George A., et al.
Publicado: (2018)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2019)

Interstitial Lung Abnormalities: An Evolving Entity
por: Tomassetti, Sara, et al.
Publicado: (2022)

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020)

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
por: Kamenova, Antoniya, et al.
Publicado: (2023)

Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives
por: Tomassetti, Sara, et al.
Publicado: (2022)

Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis
por: Samara, Katerina D., et al.
Publicado: (2017)

The 6-min walk test as a primary end-point in interstitial lung disease
por: Harari, Sergio, et al.
Publicado: (2022)

Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy
por: Margaritopoulos, George A, et al.
Publicado: (2016)

Non-specific interstitial pneumonia in cigarette smokers: a CT study
por: Marten, Katharina, et al.
Publicado: (2009)

Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020)

Predicting outcomes in rheumatoid arthritis related interstitial lung disease
por: Jacob, Joseph, et al.
Publicado: (2019)

Assembly 12: interstitial lung diseases
por: Antoniou, Katerina, et al.
Publicado: (2018)

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2018)

Interstitial pneumonia with autoimmune features: challenges and controversies
por: Mackintosh, John A., et al.
Publicado: (2021)

Comorbidities in unclassifiable interstitial lung disease
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality
por: Tsitoura, Eliza, et al.
Publicado: (2021)

Managing Lung Cancer with Comorbid Interstitial Pneumonia
por: Ichihara, Eiki, et al.
Publicado: (2019)

The natural history of progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2020)

Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior
por: Khine, Ngu, et al.
Publicado: (2020)

Sarcoidosis in a 65-year-old woman presenting with a lung mass and pericardial effusion: a case report
por: Margaritopoulos, George A, et al.
Publicado: (2012)

The King’s Brief Interstitial Lung Disease (KBILD) questionnaire: an updated minimal clinically important difference
por: Sinha, Aish, et al.
Publicado: (2019)

Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022)

Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial
por: Denton, Christopher P, et al.
Publicado: (2022)

Psychometric validation of the needs assessment tool: progressive disease in interstitial lung disease
por: Johnson, Miriam J, et al.
Publicado: (2018)

Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease
por: Jacob, Joseph, et al.
Publicado: (2018)

Self-Eating: Friend or Foe? The Emerging Role of Autophagy in Idiopathic Pulmonary Fibrosis
por: Margaritopoulos, George A., et al.
Publicado: (2013)

Reply to Althuwaybi et al.: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?
por: Chaudhuri, Nazia, et al.
Publicado: (2021)

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials
por: Khanna, Dinesh, et al.
Publicado: (2015)

Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial
por: Flaherty, Kevin R., et al.
Publicado: (2022)

Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study
por: Jacob, Joseph, et al.
Publicado: (2016)

Adult Onset Still's Disease: A Case Report with a Rare Clinical Manifestation and Pathophysiological Correlations
por: Antoniou, Katerina M., et al.
Publicado: (2013)

Residual Lung Disease at 6-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue
por: Wells, Athol U, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kcu7n6iov5n2gu5nc48vhv2kel